Diabetes, Obesity & Metabolism·18 SepReal-World Adherence Trajectories of GLP-1 Receptor Agonists Among Adults and Paediatric Patients With ObesityStudy in peoplePopulationsPaper
ADA Scientific Sessions 2026 Abstract·11 JunRisk of Suicidal Ideation and Behaviors, Depression, and Anxiety with GLP-1 Receptor Agonist Use in Children and Adolescents: A Target Trial Emulation StudyStudy in peopleInterventionsPaper
ADA Scientific Sessions 2026 Abstract·6 JunGlucagon-Like Peptide 1 Receptor Agonists Lower the Risk of Stroke and Vascular Dementia among Individuals with ObesityStudy in peopleInterventionsPaper
ADA Scientific Sessions 2026 Abstract·6 JunGLP-1 Receptor Agonists (GLP-1RAs) and Clinical Outcomes of Binge Eating DisordersStudy in peopleInterventionsPaper
ADA Scientific Sessions 2026 Abstract·5 JunGLP-1 Receptor Agonists and Cardiovascular Events in Adults with Obesity and Autoimmune Disease: A Target Trial EmulationStudy in peoplePopulationsPaper
ADA Scientific Sessions 2026 Abstract·5 JunAssociation of Newer Glucose-Lowering Drugs with Incident Parkinsonian Disorders in Older Adults with REM Sleep Behavior Disorder and Type 2 DiabetesStudy in peoplePopulationsPaper